STAT+: Justice Department targets drugmakers in new directive on combating white-collar fraud

Summary

The Justice Department issued a new directive focused on combating fraud and indicated it will pursue violations of federal pharmaceutical regulations. This represents a routine regulatory enforcement announcement with no specific company targets identified.